Holst, Jens J.

Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss

Iepsen, E. W., Lundgren, J., Dirksen, C., Jensen, J.-E., Pedersen, O., Hansen, T., Madsbad, S., Holst, J. J., & Torekov, S. S. (2015) · International Journal of Obesity

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 118

100 years of glucagon and 100 more

Wewer Albrechtsen, N. J., Holst, J. J., Cherrington, A. D., Finan, B., Gluud, L. L., Dean, E. D., Campbell, J. E., Bloom, S. R., Tan, T. M.-M., Knop, F. K., et al. (2023) · Diabetologia

Pancreatic function and diabetesDiabetes Treatment and Management

Cited by 117

Sulfonylurea compounds uncouple the glucose dependence of the insulinotropic effect of glucagon-like peptide 1.

de Heer, J., & Holst, J. J. (2007) · Diabetes

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 115

Wheat-fibre-induced changes of postprandial peptide YY and ghrelin responses are not associated with acute alterations of satiety

Weickert, M. O., Spranger, J., Holst, J. J., Otto, B., Koebnick, C., Möhlig, M., & Pfeiffer, A. F. H. (2006) · British Journal of Nutrition

Food composition and propertiesRegulation of Appetite and Obesity

Cited by 111

Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males

Sloth, B., Davidsen, L., Holst, J. J., Flint, A., & Astrup, A. (2007) · American Journal of Physiology-Endocrinology and Metabolism

Regulation of Appetite and ObesityNeuropeptides and Animal Physiology

Cited by 104

The glucagon-like peptide-1 metabolite GLP-1-(9–36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans

Meier, J. J., Gethmann, A., Nauck, M. A., Götze, O., Schmitz, F., Deacon, C. F., Gallwitz, B., Schmidt, W. E., & Holst, J. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 104

Twelve-week treatment with liraglutide as add-on to insulin in normal-weight patients with poorly controlled type 1 diabetes: a randomized, placebo-controlled, double-blind parallel study

Frandsen, C. S., Dejgaard, T. F., Holst, J. J., Andersen, H. U., Thorsteinsson, B., & Madsbad, S. (2015) · Diabetes Care

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 103

Effect of GLP ‐1 receptor agonist treatment on body weight in obese antipsychotic‐treated patients with schizophrenia: a randomized, placebo‐controlled trial

Ishøy, P. L., Knop, F. K., Broberg, B. V., Bak, N., Andersen, U. B., Jørgensen, N. R., Holst, J. J., Glenthøj, B. Y., & Ebdrup, B. H. (2017) · Diabetes, Obesity and Metabolism

Schizophrenia research and treatmentPharmacology and Obesity Treatment

Cited by 102

Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3-36

Iepsen, E. W., Lundgren, J., Holst, J. J., Madsbad, S., & Torekov, S. S. (2016) · European Journal of Endocrinology

Regulation of Appetite and ObesityAdipokines, Inflammation, and Metabolic Diseases

Cited by 101

Short‐term effects of a low carbohydrate diet on glycaemic variables and cardiovascular risk markers in patients with type 1 diabetes: Arandomized open‐label crossover trial

Ranjan, A., Schmidt, S., Damm‐Frydenberg, C., Holst, J. J., Madsbad, S., & Nørgaard, K. (2017) · Diabetes, Obesity and Metabolism

Diet and metabolism studiesDiabetes Management and Research

Cited by 101

Postprandial GLP-1, Norepinephrine, and Reactive Hypoglycemia in Dumping Syndrome

Gebhard, B., Holst, J. J., Biegelmayer, C., & Miholic, J. (2001) · Digestive Diseases and Sciences

Bariatric Surgery and OutcomesGastrointestinal motility and disorders

Cited by 92

Pituitary Adenylate Cyclase-Activating Polypeptide Stimulates Insulin and Glucagon Secretion in Humans*

Filipsson, K., Tornøe, K., Holst, J., & Ahrén, B. (1997) · The Journal of Clinical Endocrinology & Metabolism

Pancreatic function and diabetesNeuropeptides and Animal Physiology

Cited by 91

Low-carbohydrate diet impairs the effect of glucagon in the treatment of insulin-induced mild hypoglycemia: A randomized crossover study

Ranjan, A., Schmidt, S., Damm-Frydenberg, C., Steineck, I., Clausen, T. R., Holst, J. J., Madsbad, S., & Nørgaard, K. (2017) · Diabetes Care

Diabetes Management and ResearchDiet and metabolism studies

Cited by 89

Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes

Meier, J. J., Weyhe, D., Michaely, M., Senkal, M., Zumtobel, V., Nauck, M. A., Holst, J. J., Schmidt, W. E., & Gallwitz, B. (2004) · Critical Care Medicine

Hyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Treatment and Management

Cited by 89

Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes

Højberg, P. V., Zander, M., Vilsbøll, T., Knop, F. K., Krarup, T., Vølund, A., Holst, J. J., & Madsbad, S. (2008) · Diabetologia

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 89

The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers

Tan, T., Behary, P., Tharakan, G., Minnion, J., Al-Najim, W., Albrechtsen, N. J. W., Holst, J. J., & Bloom, S. R. (2017) · The Journal of Clinical Endocrinology & Metabolism

Regulation of Appetite and ObesityBariatric Surgery and Outcomes

Cited by 88

Oxyntomodulin: actions and role in diabetes

Holst, J. J., Albrechtsen, N. J. W., Gabe, M. B. N., & Rosenkilde, M. M. (2018) · Peptides

Diabetes Treatment and ManagementRegulation of Appetite and Obesity

Cited by 86

Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents

Gasbjerg, L. S., Gabe, M. B. N., Hartmann, B., Christensen, M. B., Knop, F. K., Holst, J. J., & Rosenkilde, M. M. (2018) · Peptides

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 85

KCNQ1 Long QT Syndrome Patients Have Hyperinsulinemia and Symptomatic Hypoglycemia

Torekov, S. S., Iepsen, E., Christiansen, M., Linneberg, A., Pedersen, O., Holst, J. J., Kanters, J. K., & Hansen, T. (2014) · Diabetes

Cardiac electrophysiology and arrhythmiasPancreatic function and diabetes

Cited by 84

LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men

Hagemann, C. A., Jensen, M. S., Holm, S., Gasbjerg, L. S., Byberg, S., Skov-Jeppesen, K., Hartmann, B., Holst, J. J., Dela, F., Vilsbøll, T., et al. (2022) · Cell Reports Medicine

Regulation of Appetite and ObesityDiabetes Treatment and Management

Cited by 81

Catecholamines and Pancreatic Hormones during Autonomic Blockade in Exercising Man

Galbo, H., Christensen, N. J., & Holst, J. J. (1977) · Acta Physiologica Scandinavica

Cardiovascular and exercise physiologyPancreatic function and diabetes

Cited by 81

Prolonged Successful Therapy for Hyperinsulinaemic Hypoglycaemia after Gastric Bypass: The Pathophysiological Role of GLP1 and Its Response to a Somatostatin Analogue

Myint, K. S., Greenfield, J. R., Farooqi, I. S., Henning, E., Holst, J. J., & Finer, N. (2012) · European Journal of Endocrinology

Bariatric Surgery and OutcomesPancreatic function and diabetes

Cited by 77

The incretin/glucagon system as a target for pharmacotherapy of obesity

Del Prato, S., Gallwitz, B., Holst, J. J., & Meier, J. J. (2022) · Obesity Reviews

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 77

Effects of Nicotinamide Riboside on Endocrine Pancreatic Function and Incretin Hormones in Nondiabetic Men With Obesity

Dollerup, O. L., Trammell, S. A. J., Hartmann, B., Holst, J. J., Christensen, B., Møller, N., Gillum, M. P., Treebak, J. T., & Jessen, N. (2019) · The Journal of Clinical Endocrinology & Metabolism

Sirtuins and Resveratrol in MedicinePancreatic function and diabetes

Cited by 77